The Wilson Disease copper balance study

The aim of this clinical study in people with Wilson Disease is to find out whether Alexion’s investigational product is able to help restore copper balance by promoting the removal of more copper from the body than is taken in through food and drink. This clinical study is currently recruiting, and if you would like to learn more, please contact Celerion Lincoln, Nebraska, at email: or call 866-445-7033. This clinical study is sponsored by Alexion Pharmaceuticals, Inc.

By Published On: August 11, 2021Categories: Clinical Trials

Share This Story, Choose Your Platform!